| OA | Osteoarthritis |
| iPSCs | Induced Pluripotent Stem Cells |
| 3D | Three-dimensional |
| ECM | Extracellular Matrix |
| ACI | Autologous Chondrocyte Implantation |
| MSC | Mesenchymal Stromal Cells |
| PSC | Pluripotent Stem Cells |
| hESC | Human Embryonic Stem Cells |
| FBS | Fetal Bovine Serum |
| SOX2 | SRY (sex determining region Y)-box 2 |
| OCT4 | Octamer-binding transcription factor 4 |
| CDH1 | Cadherin-1 (E-cadherin) |
| TGF-β3 | Transforming Growth Factor beta 3 |
| EB | Embryoid Body |
| ChD | Chondrogenic Differentiation |
| ChM | Chondrogenic Medium |
| PHDF | Primary Human Dermal Fibroblast |
| RT-qPCR | Reverse Transcriptase quantitative Polymerase Chain Reaction |
| FGFR3 | Fibroblast Growth Factor Receptor 3 |
| SMAD3 | SMAD Family Member 3 |
| CDH2 | Cadherin-2 (N-cadherin) |
| NCAM1 | Neural Cell Adhesion Molecule 1 |
| COL1A2 | Collagen type 1 alpha 2 chain |
| SOX9 | SRY (sex determining region Y)-box 9 |
| COL2A1 | Collagen type 2 alpha 1 chain |
| ACAN | Aggrecan |
| GAGs | Glycosaminoglycans |
| KSR | Knock-out Serum Replacement |
| SCID | Severe Combined Immunodeficiency |
| DMEM | Dulbecco Modified Eagle Medium |
| PBS | Phosphate Buffered Saline |
| EDTA | Ethylenediaminetetraacetic acid |
| NEAA | Non-essential Amino Acids |
| B2M | Beta-2-Microglobulin |
| DAPI | 4′,6-diamidino-2-phenylindole |